Back to Search
Start Over
Pharmacology of N-desmethylclozapine.
- Source :
-
Pharmacology & therapeutics [Pharmacol Ther] 2007 Aug; Vol. 115 (2), pp. 223-31. Date of Electronic Publication: 2007 May 21. - Publication Year :
- 2007
-
Abstract
- Currently available treatments for schizophrenia have limited efficacy and are generally poorly tolerated. However, among these antipsychotic agents, clozapine stands apart in having generally superior motoric tolerability and efficacy. One intriguing possibility, based on clinical correlations, receptor activity profiles and studies with animal models predictive of antipsychotic or cognitive action is that the activity of N-desmethylclozapine (NDMC), a major metabolite of clozapine, may, at least in part, underlie the unique efficacy of clozapine. In this review we compare the pharmacological properties of NDMC to those of clozapine and consider how they may contribute to the overall clinical properties of clozapine. We also consider whether NDMC, in its own right, might be a superior antipsychotic drug.
- Subjects :
- Animals
Antipsychotic Agents metabolism
Antipsychotic Agents therapeutic use
Clozapine metabolism
Clozapine therapeutic use
Humans
Receptors, Adrenergic, alpha drug effects
Receptors, Adrenergic, alpha physiology
Receptors, Dopamine drug effects
Receptors, Dopamine physiology
Receptors, Histamine drug effects
Receptors, Histamine physiology
Receptors, Muscarinic drug effects
Receptors, Muscarinic physiology
Receptors, Opioid drug effects
Receptors, Opioid physiology
Receptors, Serotonin drug effects
Receptors, Serotonin physiology
Schizophrenia drug therapy
Antipsychotic Agents pharmacology
Clozapine analogs & derivatives
Clozapine pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 0163-7258
- Volume :
- 115
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Pharmacology & therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 17583355
- Full Text :
- https://doi.org/10.1016/j.pharmthera.2007.05.004